The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration
Open accessPublished version of a preprint
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Complement overactivation mediates microglial synapse elimination in neurological diseases such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD), but how complement activity is regulated in the brain remains largely unknown. We identified that the secreted neuronal pentraxin Nptx2 binds complement C1q and thereby regulates its activity in the brain. Nptx2-deficient mice show increased complement activity, C1q-dependent microglial synapse engulfment, and loss of excitatory synapses. In a neuroinflammation culture model and in aged TauP301S mice, adeno-associated virus (AAV)–mediated neuronal overexpression of Nptx2 was sufficient to restrain complement activity and ameliorate microglia-mediated synapse loss. Analysis of human cerebrospinal fluid (CSF) samples from a genetic FTD cohort revealed reduced concentrations of Nptx2 and Nptx2-C1q protein complexes in symptomatic patients, which correlated with elevated C1q and activated C3. Together, these results show that Nptx2 regulates complement activity and microglial synapse elimination in the brain and that diminished Nptx2 concentrations might exacerbate complement-mediated neurodegeneration in patients with FTD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Experimental evidence further suggests that downregulation of NPTX2 may lead to increased complement-mediated microglial activation, thereby causing abnormal elimination of synapses [43].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 1×
“Blocking C1q binding to neurons is sufficient to attenuate synapse loss in mouse models of AD, FTD, and Huntington’s disease (7, 11, 13).”
BackgroundThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729 · cited 3×
“…to modestly raised CCP activity and moderate loss of excitatory synapses in Nptx2 KO or C4-overexpressing mice, C1q and downstream complement components are highly up-regulated in many chronic neurodegenerative diseases, including AD, FTD, and Huntington ’ s disease ( 7 – 9 , 11 , 13 , 36 , 47 ).”
BackgroundA complement–microglial axis drives synapse loss during virus-induced memory impairment
Vasek, M. J., Garber, C., Dorsey, D., Durrant, D. M., Bollman, B., Soung, A., Yu, J., Perez-Torres, C., Frouin, A., Wilton, D. K., et al. (2016) · Nature · doi:10.1038/nature18283 · Cited by 671 · cited 1×
“This process is overactivated in several central nervous system (CNS) diseases, including AD, virus-induced synapse loss, fronto-temporal dementia (FTD), Huntington ’ s disease, and perhaps schizophrenia, leading to synapse loss and subsequent cognitive decline ( 6 – 12 ).”
BackgroundComplement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593 · cited 2×
“…to modestly raised CCP activity and moderate loss of excitatory synapses in Nptx2 KO or C4-overexpressing mice, C1q and downstream complement components are highly up-regulated in many chronic neurodegenerative diseases, including AD, FTD, and Huntington ’ s disease ( 7 – 9 , 11 , 13 , 36 , 47 ).”
BackgroundDejanovic, B., Huntley, M. A., De Mazière, A., Meilandt, W. J., Wu, T., Srinivasan, K., Jiang, Z., Gandham, V., Friedman, B. A., Ngu, H., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.014 · Cited by 517 · cited 8×
“…has been described for a therapeutical C1q-neutralizing antibody that binds to the head domain of C1q and prevents the interaction of C1q with diverse ligands ( 41 , 42 ), including synapses ( 7 ), and is currently in clinical trials for Hun-tington ’ s disease and amyotrophic lateral sclerosis.”
BackgroundInfluentialSelf-citationSynaptic clustering of AMPA receptors by the extracellular immediate-early gene product narp.
O’Brien, R. J., Xu, D., Petralia, R. S., Steward, O., Huganir, R. L., & Worley, P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80782-5 · Cited by 471
Self-citationWu, T., Dejanovic, B., Gandham, V. D., Gogineni, A., Edmonds, R., Schauer, S., Srinivasan, K., Huntley, M. A., Wang, Y., Wang, T.-M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.060 · Cited by 466
Self-citation
Cited by
Items 101–152 of 152
Progress of Chinese Medicine in Regulating Microglial Polarization against Alzheimer’s Disease
Yang, F., Gao, W., Wang, J. Z., Li, X., & Li, H. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500873 · Cited by 2
Knorr, U., Simonsen, A. H., Nilsson, J., Brinkmalm, A., Zetterberg, H., Blennow, K., Knudsen, M. B., Forman, J. L., Miskowiak, K. W., Hasselbalch, S. G., et al. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.03.005 · Cited by 1
Ryu, T., Kim, S., Thuraisamy, T., Shin, J., Jang, Y., Kam, T., & Na, C. H. (2025) · Advanced Science · doi:10.1002/advs.202409318 · Cited by 2
Göteson, A., Nilsson, J., Camporesi, E., Klahn, A. L., Hörbeck, E., Sigström, R., Jönsson, L., Sparding, T., Pålsson, E., Pelanis, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76187-y · Cited by 1
Liu, R., Kowal, T., Chow, C., Olson, T., Nguyen, E., Yang, S., Lee, J., Cai, H. “., Yang, X., & Blencowe, M. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00361-0 · Cited by 1
Stokkel, M. E., Vermunt, L., Knol, J. C., Chiasserini, D., Parnetti, L., Piersma, S. R., Pham, T. V., Haas, R. R. D. G., Lemstra, A. W., Pijnenburg, Y. A. L., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70278 · Cited by 1
Value of synaptic proteins as biomarkers in amyotrophic lateral sclerosis
Hobin, F., Das, S., Lambrechts, C., Rocker, C. D., Dubin, J., Ombelet, F., Vocht, J. D., Lamaire, N., Vanmechelen, E., Poesen, K., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag247 · Cited by 1
Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
Xu, B., Ling, Y., Liu, L., Liu, Y., Lin, Y., Lyu, J., & Zhang, Y. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05104-z · Cited by 2
Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
Prinse, F., Houwer, J. F. H. D., Dopper, E. G. P., & Seelaar, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_9 · Cited by 1
Heterogeneous complement and microglia activation mediates stress-induced synapse lossPreprint
Soteros, B. M., Tillmon, H., Wollet, M., General, J., Chin, H., Lee, J. B., Carreno, F. R., Morilak, D. A., Kim, J. H., & Sia, G.-M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.28.546889 · Cited by 1
Zhang, L., Zhu, Y., & Zhang, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.05.647412 · Cited by 1
Wang, H., Xiong, M., Jiang, Z., Hong, R., & Tian, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4856289
Exploratory Blood Biomarker Patterns in a Mixed Dementia CohortPreprint
Gezegen, H., Alaylıoğlu, M., Şahin, E., Swann, O., Veleva, E., Güven, G., Yaman, Ü., Salih, D. A. M., Bılgıç, B., Hanağası, H. A., et al. (2024) · medRxiv · doi:10.1101/2024.11.07.24316927 · Cited by 1
Xixin Decoction May Treat Vascular Dementia by Modulating the NPTX2/C1q/C3 Complement Pathway
Yang, S., Gao, X., Tan, A., & Ge, P. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402208
Sánchez-Carbonell, M., Bolshakova, S., Ávila-Pagán, J. E., Sabir, Y. A., Griffin-Derr, C., Stich, D., Cieslewicz, S. V., Carmen-Sifuentes, S., Phadke, R. A., Brack, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656749
Lizama, B. N., Shin, R. S., North, H. A., Look, G. C., Reaver, A., Pandey, K., Duong, D. M., Seyfried, N. T., Caggiano, A. O., & Hamby, M. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.20.660336
Hu, G., Wang, K., Wu, C., Liu, Q., Zhang, Q., Ai, Q., & Huang, M. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02374-z
Dulski, J., Boddapati, A. K., Risi, B., Iruzubieta, P., Orlacchio, A., Fernández‐Torrón, R., Castillo‐Triviño, T., de Munain, A. L., Vucic, S., Padovani, A., et al. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100498 · Cited by 4
BA9 Transcriptomics in Huntington’s Disease 80-Gene Signature and MIR219A2-Linked Targets
Öztan, G., İşsever, H., & ŞAHİN, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188934
Liu, X.-Y., Yan, Y.-Z., Jiang, A.-J., He, W.-Y., Fang, Y., Li, C., Deng, M., Tan, S.-J., & Zeng, P. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-23296-1 · Cited by 3
Das, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E., & Verberk, I. M. W. (2024) · Figshare · doi:10.6084/m9.figshare.25223556
Das, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E., & Verberk, I. M. W. (2024) · Figshare · doi:10.6084/m9.figshare.25223869
Xu, B., Ling, Y., Liu, L., Liu, Y., Lin, Y., Lyu, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25989206
Kaya, S., Kocabaş, R., Sağlıyan, B., Bayırlı, Ö., Yorulmaz, A. E., & Kandeğer, A. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02190-x
Severín, D., & Kirkwood, A. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1819500
Zambrano‐Astorga, M. F., Moreno‐Ulloa, A., & Initiative, T. A. D. N. (2026) · medRxiv · doi:10.64898/2026.04.26.26351766
Wang, H., Bundo, M., Nakachi, Y., Kanai, A., Yamamoto, Y., Miyazaki, H., Toyoshima, F., Shima, Y., Sakai, M., Yu, Z., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03629-w · Cited by 1
Zhang, S., Zhao, X., Tian, Q., Liu, C., Jiang, S., Wang, G., Xiang, X., Liao, J., & Li, M. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111941
Chen, L., Yang, N., Zhang, F., Lv, F., Tan, N., Zhang, Y., & Wu, G. (2026) · Discover Oncology · doi:10.1007/s12672-026-05307-3
The neuroimmune system and cognition
Klein, R. S. (2026) · Nature Immunology · doi:10.1038/s41590-026-02560-0 · Cited by 3
Dunlop, S. R., Lincoln, S., Peng, Z., Graff‐Radford, N. R., Lachner, C., Day, G. S., Tranovich, J. F., Reichard, R. R., Dickson, D. W., Petersen, R. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.735558
Complement dysregulation during the early phases of synucleinopathy
Khan, H., Gifford, M., Kordbacheh, A., Bury, A., Panoushek, S., Cole-Strauss, A., Kemp, C. J., Luk, K. C., Steece‐Collier, K., Kuhn, N. C., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03057-8
Moreno‐Castro, C., Arroyo, M. N., Benabdallah, K., Olazagoitia‐Garmendia, A., Santacreu, B. J., Sawatani, T., Green, J., Pachera, N., Cosentino, C., Communi, D., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7198220
Ji, Y., Liu, S., Zhang, Y., Jq, Z., Huang, C., ZHAO, Y., Xia, J., Mu, W., Yao, J. L., & Yan, B. (2026) · MedComm · doi:10.1002/mco2.70879
Microglial pathological synaptic pruning in epilepsy: pathophysiology and therapeutic potential
Sun, Y., Zhou, D., Li, J., Wu, H., Liang, J., & Zhang, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1843165
Zhang, L., Wu, M., Pan, T., Dan, D., & Xue, S. (2026) · The FASEB Journal · doi:10.1096/fj.202601523r
Complosome as a key modulator of cellular senescence, aging and age-related diseases
Gold, N. M., Okeke, M. N., Ewhea, A. S., & He, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103274 · Cited by 1
Correlation analysis between complement proteins and Alzheimer's disease
Lu, Y.-T., Guo, Z.-M., Liu, M.-Y., Ji, C., Luo, Y., Zhou, S.-Y., Ma, T., Zhu, X.-C., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261475358
Kumar, A., Sharma, M., Su, Y., Singh, S., Tanley, J. E., Casanova, R., Hsu, F., Craft, S., Mielke, M. M., Hughes, T. M., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71717
Lizama, B. N., Shin, R. S., North, H. A., Look, G., Reaver, A., Pandey, K., Duong, D., Seyfried, N. T., Caggiano, A. O., & Hamby, M. E. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00321-1
Tang, N., Xia, F., Freasier, H., Tien, P. C., Glesby, M. J., Merenstein, D., French, A. L., McKay, H., Diaz, M. M., Ofotokun, I., et al. (2026) · Cells · doi:10.3390/cells15171581
Cytoskeletal alterations underlying dendritic and synaptic plasticity in epilepsy
Li, S., Zhu, Y., Gong, C., & Chen, Y. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.08.053
Jeong, H., Kang, Y., Jeong, S., Yoo, J. M., Choi, Y. S., Kwon, S. H., Hwang, H., Nahm, M., & Kim, D. (2026) · Nanomaterials · doi:10.3390/nano16181158
Chen, Y., Li, S., Lin, H., Zou, F., & Wang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1936082
B cells enter the synaptic conversation
Suk, T. R., & Gate, D. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.09.004
Spillman, A. M., Alsop, E. B., Gittings, L. M., Garcia‐Mansfield, K., Piras, I. S., Bonfitto, A., Martinez, M. N., Sharma, R., Preller, K. R., Huentelman, M. J., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03084-5
Complement-mediated synaptic loss in inflammatory depression: mechanisms and therapeutic prospects
Ye, F., Qiu, S., Chen, Y., Xu, J., & Wang, H. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107027
Wang, T., Wang, L., Cao, J., Zhao, Y., He, Z., & Lu, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1956600
CD8+ t cell-mediated regulation of synaptic integrity in Alzheimer’s disease
Fu, H., Yang, J., & Zhang, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1903001
Zou, Z., Zhao, J., Han, W., Meng, P., Yang, H., Xi, J., Lei, T., Li, W., Shi, R., Wang, Y., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116050
Sánchez-Carbonell, M., Bolshakova, S., Ávila-Pagán, J. E., Sabir, Y. A., Griffin-Derr, C., Stich, D., Cieslewicz, S. V., Sifuentes, S. E. C., Phadke, R. A., Brack, A., et al. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014871
Dejanovic, B., Figley, M. D., Weisman, E. F., Kiragasi, B., Gergits, F. W., Larson, K., Renoux, A. J., Rajagovindan, R., Pandya, B. A., Houze, J. B., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aec5740 · Cited by 2
Self-citation
Metadata
- Authors
- Zhou, J., Wade, S. D., Graykowski, D., Xiao, M.-F., Zhao, B., Giannini, L. A. A., Hanson, J. E., van Swieten, J. C., Sheng, M., Worley, P. F., & Dejanovic, B.
- Affiliations
- Johns Hopkins University (US)
- Broad Institute (US)
- Erasmus MC (NL)
- Genentech (US)
- Alzheimer Center, Department of Neurology, Erasmus University Medical Center, Rotterdam, 3015 GD, Netherlands.
- Corresponding author
- Sheng, Morgan
- Worley, Paul F.
- Dejanovic, Borislav
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2023-03-29
- Volume
- 15
- Issue
- 689
- Pages
- eadf0141-eadf0141
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC10467038
- OpenAlex
- W4361290848
- Cited by
- 152
- References
- 58
- Citations by year
- 2026: 43 · 2025: 53 · 2024: 38 · 2023: 18
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Translational Medicine (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (AG065169)
- Stanley Center for Psychiatric Research, Broad Institute
- National Institute on Aging (P01AG009973, R01AG072643, U19AG065169)
- National Institute of Neurological Disorders and Stroke (R35NS097966)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NPTX2, C1q, complement overactivation, microglia, synaptic pruning, neurodegeneration, frontotemporal dementia, Alzheimer's disease, neuroinflammation, tauopathy, cerebrospinal fluid biomarkers, C3 activation, AAV gene therapy
- MeSH terms
- Pentraxins, Aged, Animals, Complement System Proteins, Humans, Synapses, Complement C1q, Microglia, Mice, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.